Stay updated with breaking news from Spin Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for "off-the-shelf" cell therapy to treat challenging cancers.
Los Angeles-based biotechnology company Appia Bio said this morning that it has named Robert S. Negrin, M.D., to its Scientific Advisory Board. Dr. Negrin is a professor of medicine and former chief of th
/PRNewswire/ -- Appia Bio, Inc., a preclinical-stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs)...
Diarrhea is the second-leading cause of death among children worldwide
/PRNewswire/ -- In response to overwhelming customer demand, TetraScience announced today the evolution of its industry leading data cloud to include...